ZYGMONT CHESTER STANLEY III (Chief Financial Officer) reported 1 transaction at REVELATION BIOSCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/1/2026ACC: 0001193125-26-201764
Officer· Chief Financial Officer
Since Jan 2022
-13.29K
Net shares
Net seller
$14.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.29K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−13.29K
Price / share
$1.10
Trade value
$14.61K
% of position
12.6%
4/30/2026
105.35K→92.06K
Total
Net shares
−13.29K
Net value
-$14.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/30/2026 | F · Tax Withholding | −13.29K | $1.10 | $14.61K | 12.6% | 105.35K | 92.06K |
| Total | −13.29K | -$14.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.00
Total
2.00 indirect2.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.00 | Indirect |
| Total | 2.00 | 2.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported